Day: March 18, 2026

SOUTH SAN FRANCISCO, Calif., March 17, 2026 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq:CTMX), a leader in the field of masked, conditionally activated biologics, today announced the pricing of an underwritten public offering of 45,990,567 shares of its common stock at a price to the public of $5.30 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 1,179,245 shares of common stock. The gross proceeds to CytomX from the offering are expected to be $250 million, before deducting underwriting discounts and commissions and estimated offering expenses. In addition, CytomX granted the underwriters a 30-day option to purchase up to an additional 7,075,471 shares of its common stock at the public offering price, less underwriting discounts and commissions. The closing of the offering is...

MIAMI, March 17, 2026 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced the pricing of an underwritten public offering of 19,324,677 shares of its common stock at a public offering price of $3.85 per share, and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 2,753,246 shares of common stock at a public offering price of $3.8499 per pre-funded warrant, which represents the per share public offering price less the $0.0001 per share exercise price for each pre-funded warrant. Gross proceeds from the offering are expected to be approximately $85 million, before deducting underwriting discounts and commissions and...

VANCOUVER, British Columbia, March 17, 2026 (GLOBE NEWSWIRE) — Eco Oro Minerals Corp. (CSE: EOM) (“Eco Oro” or the “Company”) announces it has completed the second tranche of a previously announced private placement (the “Private Placement”) of 2025 contingent value rights certificates (“2025 CVRs”). The Private Placement was completed in two tranches: (i) a first tranche of US$4,000,000 of 2025 CVRs completed on August 7, 2025 and (ii) a second tranche of US$500,000 of 2025 CVRs completed on March 16, 2026. The proceeds of the Private Placement will be principally used to support the Company’s application to annul the damages award issued on July 15, 2024 awarding no monetary compensation to the Company by the arbitral tribunal constituted under the International Centre for Settlement of Investment Disputes in its arbitration proceedings...

ROCKVILLE, Md. and SUZHOU, China, March 17, 2026 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that four abstracts highlighting the latest preclinical results from its pipeline programs have been selected for poster presentations at the American Association of Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22, 2026, in San Diego, CA, USA. The data to be presented encompasses three of the Company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor Olverembatinib (HQP1351), FAK/ALK/ROS1 tyrosine kinase inhibitor APG-2449, and PRC2/EED inhibitor APG-5918. The AACR...

Live Demos Feature SmartSwitch.ai, SmartEdge AI Gateways and FLIR-Integrated Drone Intelligence Alongside Lantronix’s Industry-Leading PoE Switching Solutions for Security, Industrial and Smart City Networks IRVINE, Calif., March 17, 2026 (GLOBE NEWSWIRE) — Lantronix Inc. (Nasdaq: LTRX), a global provider of Edge AI and Industrial IoT solutions that power NDAA-compliant unmanned systems, critical infrastructure and resilient enterprise networks, today announced it will showcase its latest intelligent switching and edge computing platforms at ISC West, held March 25–27 in Las Vegas, at booth 34073. Demonstrations will feature its new SmartSwitch.ai platform, SmartEdge gateways and its industry‑leading Power over Ethernet (PoE) switches and media converters, including solutions from Transition Networks, now part of Lantronix. ISC...